Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results
le Coutre, P D, Giles, F J, Hochhaus, A, Apperley, J F, Ossenkoppele, G J, Blakesley, R, Shou, Y, Gallagher, N J, Baccarani, M, Cortes, J, Kantarjian, H M
Published in Leukemia (01.06.2012)
Published in Leukemia (01.06.2012)
Get full text
Journal Article
Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase
Giles, F J, Kantarjian, H M, le Coutre, P D, Baccarani, M, Mahon, F-X, Blakesley, R E, Gallagher, N J, Gillis, K, Goldberg, S L, Larson, R A, Hochhaus, A, Ottmann, O G
Published in Leukemia (01.05.2012)
Published in Leukemia (01.05.2012)
Get full text
Journal Article
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
Larson, R A, Hochhaus, A, Hughes, T P, Clark, R E, Etienne, G, Kim, D-W, Flinn, I W, Kurokawa, M, Moiraghi, B, Yu, R, Blakesley, R E, Gallagher, N J, Saglio, G, Kantarjian, H M
Published in Leukemia (01.10.2012)
Published in Leukemia (01.10.2012)
Get full text
Journal Article
CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion
Gallagher, N J, Eliopoulos, A G, Agathangelo, A, Oates, J, Crocker, J, Young, L S
Published in Molecular pathology (01.04.2002)
Published in Molecular pathology (01.04.2002)
Get full text
Journal Article
Activation of the p38 Mitogen-activated Protein Kinase Pathway by Epstein-Barr Virus-encoded Latent Membrane Protein 1 Coregulates Interleukin-6 and Interleukin-8 Production
Eliopoulos, A G, Gallagher, N J, Blake, S M, Dawson, C W, Young, L S
Published in The Journal of biological chemistry (04.06.1999)
Published in The Journal of biological chemistry (04.06.1999)
Get full text
Journal Article
CD40 Induces Apoptosis in Carcinoma Cells through Activation of Cytotoxic Ligands of the Tumor Necrosis Factor Superfamily
Eliopoulos, Aristides G., Davies, Clare, Knox, Pauline G., Gallagher, Neil J., Afford, Simon C., Adams, David H., Young, Lawrence S.
Published in Molecular and Cellular Biology (01.08.2000)
Published in Molecular and Cellular Biology (01.08.2000)
Get full text
Journal Article
Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy
Giles, F J, Abruzzese, E, Rosti, G, Kim, D-W, Bhatia, R, Bosly, A, Goldberg, S, Kam, G L S, Jagasia, M, Mendrek, W, Fischer, T, Facon, T, Dünzinger, U, Marin, D, Mueller, M C, Shou, Y, Gallagher, N J, Larson, R A, Mahon, F-X, Baccarani, M, Cortes, J, Kantarjian, H M
Published in Leukemia (01.07.2010)
Published in Leukemia (01.07.2010)
Get full text
Journal Article
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial
Kantarjian, Hagop M, Prof, Hochhaus, Andreas, Prof, Saglio, Giuseppe, Prof, De Souza, Carmino, Prof, Flinn, Ian W, MD, Stenke, Leif, MD, Goh, Yeow-Tee, MD, Rosti, Gianantonio, Prof, Nakamae, Hirohisa, MD, Gallagher, Neil J, MD, Hoenekopp, Albert, MD, Blakesley, Rick E, PhD, Larson, Richard A, Prof, Hughes, Timothy P, Prof
Published in The lancet oncology (01.09.2011)
Published in The lancet oncology (01.09.2011)
Get full text
Journal Article
The effect of nilotinib on major molecular responses (MMR) compared with imatinib in Japanese patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): Results from the Japanese subset of ENESTnd
Hino, M., Matsumura, I., Kurokawa, M., Amagasaki, T., Yanada, M., Gallagher, N. J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
The incidence of BCR-ABL mutations in patients (pts) with newly diagnosed chronic myeloid leukemia (CML) in chronic phase (CP) treated with nilotinib or imatinib in ENESTnd: 24-month follow-up
Saglio, G., Kantarjian, H., Reiffers, J., Jootar, S., Kalaycio, M. E., Shibayama, H., Fan, X., Gallagher, N. J., Shou, Y., Larson, R. A., Hughes, T. P., Hochhaus, A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Comparison of nilotinib and imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): ENESTnd 24-month follow-up
Larson, R. A., Kim, D., Rosti, G., Stenke, L., Pasquini, R., Hoenekopp, A., Blakesley, R. E., Gallagher, N. J., Hochhaus, A., Hughes, T. P., Saglio, G., Kantarjian, H.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Effect of the proton pump inhibitor esomeprazole on the oral absorption and pharmacokinetics of nilotinib
Gallagher, N. J., Fischer, D., Demirhan, E., Zhou, W., Golor, G., Schran, H., Yin, O.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Effect of nilotinib on the pharmacokinetics and pharmacodynamics of warfarin
Yin, O., Gallagher, N. J., Fischer, D., Zhao, L., Zhou, W., Golor, G., Schran, H.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up: This article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue
LARSON, R. A, HOCHHAUS, A, BLAKESLEY, R. E, GALLAGHER, N. J, SAGLIO, G, KANTARJIAN, H. M, HUGHES, T. P, CLARK, R. E, ETIENNE, G, KIM, D.-W, FLINN, I. W, KUROKAWA, M, MOIRAGHI, B, YU, R
Published in Leukemia (2012)
Get full text
Published in Leukemia (2012)
Journal Article
Erratum: Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
Larson, R A, Hochhaus, A, Hughes, T P, Clark, R E, Etienne, G, Kim, D-W, Flinn, I W, Kurokawa, M, Moiraghi, B, Yu, R, Blakesley, R E, Gallagher, N J, Saglio, G, Kantarjian, H M
Published in Leukemia (10.10.2012)
Published in Leukemia (10.10.2012)
Get full text
Journal Article